ALDR1EUR

Alder Biopharmaceuticals Inc

A biotechnology company that develops therapeutic antibodies, best known for creating the migraine-prevention medicine eptinezumab (brand name Vyepti), the first such treatment given by IV infusion. Founded in 2004 in Bothell, Washington, by former Celltech researchers, it was later bought by the Danish pharma firm H. Lundbeck and renamed Lundbeck Seattle Biopharmaceuticals. Fun fact: its name comes from the alder tree, a nod to the Pacific Northwest where the company was born.